TY - JOUR
T1 - How did we get a COVID-19 vaccine in less than 1 year?
AU - The AACR COVID-19 and Cancer Task Force
AU - Wherry, E. John
AU - Jaffee, Elizabeth M.
AU - Warren, Nicholas
AU - D'Souza, Gypsyamber
AU - Ribas, Antoni
N1 - Publisher Copyright:
© 2021 American Association for Cancer Research.
PY - 2021/4
Y1 - 2021/4
N2 - The successful development of COVID-19 vaccines within an unprecedented short time needs to be followed by rapid vaccine uptake, in particular, in high-risk populations such as patients with cancer. It is important for the scientific research community and cancer physicians to convey the knowledge behind the COVID-19 vaccine development and contribute to build the required trust on their use.
AB - The successful development of COVID-19 vaccines within an unprecedented short time needs to be followed by rapid vaccine uptake, in particular, in high-risk populations such as patients with cancer. It is important for the scientific research community and cancer physicians to convey the knowledge behind the COVID-19 vaccine development and contribute to build the required trust on their use.
UR - http://www.scopus.com/inward/record.url?scp=85104124659&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104124659&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-21-0079
DO - 10.1158/1078-0432.CCR-21-0079
M3 - Review article
C2 - 33542081
AN - SCOPUS:85104124659
SN - 1078-0432
VL - 27
SP - 2136
EP - 2138
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 8
ER -